Epitomics
Pioneering groundbreaking monoclonal antibody technology with unmatched binding affinity, specificity, and bioactivity for research and diagnostics.
General Information
BounceWatch is an independent company data service, not affiliated with Epitomics. To contact Epitomics, visit epitomics.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Epitomics compare?
A PDF of Epitomics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Epitomics soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Epitomics on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
About Epitomics
Business keywords: Monoclonal Antibodies, RabMAb® Technology, Research, Diagnostics, Innovation, California, Hong Kong, China, Antibody Technology, Bioactivity, Specificity, Binding Affinity, Emerging Company, Proprietary Technology
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | Undisclosed | 1 |
|
01 Jan 2001 |
Epitomics Alternatives & Competitors
View All Alternatives
Antibody Manufacturer and Supplier | High-Quality Rabbit and Goat Monoclonal Antibodies
Recombinant monoclonal antibodies and membrane proteins for drug discovery.
Discovery of innovative therapeutic antibodies for human and animal health
FAQ About Epitomics
Source: BounceWatch company record for Epitomics, https://bouncewatch.com/company/epitomics, updated 27 October 2024. When citing, please name BounceWatch and link this page.
